StockWatch
·
Biotechnology: Electromedical & Electrotherapeutic Apparatus
AcquisitionsAug 3, 2026, 06:42 AM

Integer Holdings to be Acquired by KKR for $5.7B; Q2 Sales Down 2.6%

AI Summary

Integer Holdings Corporation announced it has entered into a definitive agreement to be acquired by an affiliate of investment funds managed by KKR in an all-cash transaction valued at an enterprise value of $5.7 billion. Under the terms, stockholders will receive $127 per share. Concurrently, the company reported its second quarter 2026 results, with sales decreasing 2.6% to $464 million and GAAP operating income falling 42% to $35 million. Due to the pending transaction, Integer has withdrawn its financial outlook and canceled its scheduled earnings conference call.

Key Highlights

  • KKR to acquire Integer Holdings for an enterprise value of $5.7 billion.
  • Integer stockholders to receive $127 per share in cash.
  • Company withdrew its previously issued financial outlook and canceled earnings call.
  • Q2 2026 sales decreased 2.6% to $464 million; organic sales decreased 1.5%.
  • GAAP operating income from continuing operations decreased 42% to $35 million.
  • GAAP diluted EPS from continuing operations decreased 34% to $0.69.
  • Non-GAAP adjusted EPS increased 3% to $1.60.
  • Cardio & Vascular sales decreased 2% to $280 million.